UpStream Bio Inc.(UPB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UPB UpStream Bio Inc.

盘后交易 02-18 18:20:20 EST

8.29

-0.04

-0.48%

盘后8.28

-0.01-0.12%

18:17 EST

最高8.66	最低7.93	成交量288.69万
今开8.18	昨收8.33	日振幅8.76%
总市值4.48亿	流通市值2.60亿	总股本5,404万
成交额2,412万	换手率9.19%	流通股本3,142万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":8.29,"timestamp":1771448400000,"preClose":8.33,"halted":0,"volume":2886938,"hourTrading":{"tag":"盘后","latestPrice":8.28,"preClose":8.29,"latestTime":"18:17 EST","volume":16079,"amount":133191.795373,"timestamp":1771456668803,"change":-0.01,"changeRate":-0.001206,"amplitude":0.015682},"delay":0,"changeRate":-0.004801920768307434,"floatShares":31417476,"shares":54038591,"eps":-2.274,"marketStatus":"盘后交易","change":-0.04,"latestTime":"02-18 18:20:20 EST","open":8.18,"high":8.66,"low":7.93,"amount":24115132.971406,"amplitude":0.087635,"askPrice":8.39,"askSize":1500,"bidPrice":8.21,"bidSize":222,"shortable":3,"etf":0,"ttmEps":-2.274,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771462800000},"marketStatusCode":4,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":8.33,"preHourTrading":{"tag":"盘前","latestPrice":8.19,"preClose":8.33,"latestTime":"09:27 EST","volume":1657,"amount":13826.884553,"timestamp":1771424848895,"change":-0.14,"changeRate":-0.016807,"amplitude":0.072773},"postHourTrading":{"tag":"盘后","latestPrice":8.28,"preClose":8.29,"latestTime":"18:17 EST","volume":16079,"amount":133191.795373,"timestamp":1771456668803,"change":-0.01,"changeRate":-0.001206,"amplitude":0.015682},"volumeRatio":0.55395,"impliedVol":2.1717,"impliedVolPercentile":0.9063},"requestUrl":"/m/hq/s/UPB","defaultTab":"news","newsList":[{"id":"1170657934","title":"Upstream Bio公布Verekitug治疗重症哮喘II期Valiant试验积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1170657934","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170657934?lang=zh_cn&edition=full","pubTime":"2026-02-11 19:01","pubTimestamp":1770807683,"startTime":"0","endTime":"0","summary":"生物制药公司Upstream Bio近日宣布，其用于治疗重症哮喘的在研药物Verekitug，在II期Valiant临床试验中取得了积极的顶线结果。\n该试验数据表明，Verekitug在主要疗效终点上表现出显著优势，达到了预设的统计学标准。这一积极结果标志着Verekitug在治疗重症哮喘这一未满足巨大医疗需求的领域取得了重要进展，为后续的临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2610609525","title":"Upstream Bio, Inc.盘中异动 大幅上涨5.07%报27.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610609525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610609525?lang=zh_cn&edition=full","pubTime":"2026-02-11 01:34","pubTimestamp":1770744859,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日01时34分，Upstream Bio, Inc.股票出现波动，股价急速拉升5.07%。截至发稿，该股报27.45美元/股，成交量17.7095万股，换手率0.33%，振幅5.86%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211013419a6eb6aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211013419a6eb6aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSLP","UPB"],"gpt_icon":0},{"id":"2609058293","title":"Upstream Bio, Inc.盘中异动 早盘股价大跌5.03%报29.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609058293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609058293?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:15","pubTimestamp":1770218156,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时15分，Upstream Bio, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报29.24美元/股，成交量9.3707万股，换手率0.17%，振幅4.97%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231556953fd698&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231556953fd698&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UPB","TSLP","BK4139"],"gpt_icon":0},{"id":"2607708320","title":"Upstream Bio, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607708320?lang=zh_cn&edition=full","pubTime":"2026-01-29 00:33","pubTimestamp":1769618031,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日00时33分，Upstream Bio, Inc.股票出现波动，股价大幅下挫5.12%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129003351a6b8183e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129003351a6b8183e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"gpt_icon":0},{"id":"2605000402","title":"Upstream Bio, Inc.盘中异动 临近午盘股价大跌5.06%报30.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605000402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605000402?lang=zh_cn&edition=full","pubTime":"2026-01-24 00:50","pubTimestamp":1769187042,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时50分，Upstream Bio, Inc.股票出现异动，股价大幅下挫5.06%。截至发稿，该股报30.18美元/股，成交量8.2757万股，换手率0.15%，振幅3.90%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124005042953e20b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124005042953e20b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UPB","TSLP","BK4139"],"gpt_icon":0},{"id":"2601524458","title":"Upstream Bio, Inc.盘中异动 股价大跌5.06%报25.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601524458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601524458?lang=zh_cn&edition=full","pubTime":"2026-01-06 02:05","pubTimestamp":1767636308,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日02时05分，Upstream Bio, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报25.70美元/股，成交量20.6153万股，换手率0.38%，振幅6.10%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010602050997a10fd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010602050997a10fd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UPB","TSLP","BK4139"],"gpt_icon":0},{"id":"2594233385","title":"Upstream Bio, Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594233385?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:12","pubTimestamp":1766589144,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日23时12分，Upstream Bio, Inc.股票出现异动，股价快速拉升5.31%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1756.82%、1126.59%、54.08%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.，振幅分别为62.58%、52.88%、23.04%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224231225a6cae61c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224231225a6cae61c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"gpt_icon":1},{"id":"2583529595","title":"Upstream Bio, Inc.2025财年第三财季实现净利润-33.75百万美元，同比减少111.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583529595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583529595?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:00","pubTimestamp":1763049659,"startTime":"0","endTime":"0","summary":"11月14日，Upstream Bio, Inc.公布财报，公告显示公司2025财年第三财季净利润为-33.75百万美元，同比减少111.07%；其中营业收入为683000.00美元，同比增加12.52%，每股基本收益为-0.63美元。从资产负债表来看，Upstream Bio, Inc.总负债12.61百万美元，其中短期债务716000.00美元，资产负债比为0.32，流动比率为0.33。机构评级：截至2025年11月14日，当前有3家机构对Upstream Bio, Inc.目标价做出预测，其中目标均价为52.33美元，其中最低目标价为35.00美元，最高目标价为75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000227950290a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000227950290a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"gpt_icon":1},{"id":"1130035913","title":"UpStream Bio Inc.：未观察到严重不良事件 安全性表现良好且与前期研究结果一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1130035913","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130035913?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:03","pubTimestamp":1756807381,"startTime":"0","endTime":"0","summary":"UpStream Bio Inc.宣布，在研究中未观察到严重不良事件，药物整体耐受性良好，安全性表现与此前的研究结果保持一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"1116725214","title":"UpStream Bio Inc.公布Verekitug治疗慢性鼻窦炎伴鼻息肉2期临床试验积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1116725214","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116725214?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:01","pubTimestamp":1756807283,"startTime":"0","endTime":"0","summary":"UpStream Bio Inc.宣布，其针对慢性鼻窦炎伴鼻息肉(CRSwNP)治疗药物Verekitug的2期临床试验Vibrant获得积极的顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2486705257","title":"单月超6亿美元，医药企业IPO规模重返疫情前水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705257","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705257?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:34","pubTimestamp":1732527240,"startTime":"0","endTime":"0","summary":"今年以来，生物医药领域已经有30家公司IPO上市，累计融资规模超40.49亿美元，其中不乏CG Oncology、Kyverna Therapeutics等IPO规模超3亿美元的公司。在多肽类PTH1R激动剂领域，阿斯利康以总价18亿美元收购AmolytPharma，获得了处于临床3期的PTH1R激动剂eneboparatide，目前该疗法已经获得了FDA快速通道认定，另一家药企AscendisPharma的Yorvipath获得FDA批准上市，用于治疗成人慢性甲状旁腺功能减退。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhqmk8147031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GLYC","BK4200","BK4599","AVTE","QID","UPB","NQmain","SEPN","OMGA","CAMP","QLD","BK4007","ASO","BK4139","BK4539","PSQ","BK4082","BK4020","APGE","MNQmain","BDMD",".IXIC","TSLP","BK4561","GPCR","TQQQ","SYRS","SQQQ"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.upstreambio.com","stockEarnings":[{"period":"1week","weight":-0.7005},{"period":"1month","weight":-0.7313},{"period":"3month","weight":-0.666},{"period":"6month","weight":-0.5304},{"period":"1year","weight":0.0961},{"period":"ytd","weight":-0.6932}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Upstream Bio, Inc.于2021年4月在特拉华州注册成立。他们是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。他们正在开发verekitug，这是目前临床开发中唯一已知的拮抗剂，靶向胸腺间质淋巴细胞生成素（“TSLP”）受体，TSLP是一种细胞因子，是临床验证的炎症反应驱动因素，位于影响各种免疫介导疾病的多个信号级联的上游。迄今为止的临床前和临床数据表明，verekitug对TSLP受体具有高度有效的抑制作用，这将转化为差异化的产品特征，包括改善临床结果、大幅延长给药间隔和治疗广泛患者的潜力。他们经验丰富的团队致力于最大限度地发挥verekitug的独特属性，以满足当今护理标准无法满足的患者的大量未满足需求。","exchange":"NASDAQ","name":"UpStream Bio Inc.","nameEN":"UpStream Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"UpStream Bio Inc.(UPB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供UpStream Bio Inc.(UPB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"UpStream Bio Inc.,UPB,UpStream Bio Inc.股票,UpStream Bio Inc.股票老虎,UpStream Bio Inc.股票老虎国际,UpStream Bio Inc.行情,UpStream Bio Inc.股票行情,UpStream Bio Inc.股价,UpStream Bio Inc.股市,UpStream Bio Inc.股票价格,UpStream Bio Inc.股票交易,UpStream Bio Inc.股票购买,UpStream Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"UpStream Bio Inc.(UPB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供UpStream Bio Inc.(UPB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}